# Blood Spot Self-administered Test and Assay

> **NCT03840824** · — · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 80 (actual)

## Conditions studied

- Dysfunction; Endocrine
- Effects of Chemotherapy
- Premature Ovarian Failure

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03840824
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2016-06
- **Final completion:** 2016-08
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2020-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03840824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03840824, "Blood Spot Self-administered Test and Assay". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03840824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*